The Top 5 Performing Dow Stocks Coming Out of the Brexit

Photo of Chris Lange
By Chris Lange Updated Published
The Top 5 Performing Dow Stocks Coming Out of the Brexit

© Thinkstock

Looking at what was a brief but massive fallout within broad markets, we are realizing that the Brexit provided a very attractive entry point into a fair number of industries. The Dow Jones Industrial Average (DJIA) was no exception.

Although the DJIA initially dropped practically 800 points following the Brexit news, the index is now back near its pre-Brexit levels.

24/7 Wall St. has picked some of the leading companies in the DJIA and tracked them since the Brexit. We have included a recent trading history, consensus analyst price target, and 52-week trading range.

[nativounit]

The Travelers Companies, Inc. (NYSE: TRV) saw its stock drop as low as $109.33 on Monday but since then it has recovered handily (7%). Shares of Travelers closed Friday at $118.85, with a consensus analyst price target of $112.78 and a 52-week trading range of $95.21 to $119.30.

Nike, Inc. (NYSE: NKE) watched its shares make a decent gain over the week with the stock up over 5% during this time. Shares of Nike closed the week at $55.61, with a consensus analyst price target of $66.81 and a 52-week trading range of $47.25 to $68.19.

General Electric Co. (NYSE: GE) saw its shares gain about 5.6% over the course of the week. The stock last closed at $31.49, with a consensus analyst price target of $32.53 and a 52-week trading range of $19.37 to $32.05.

Exxon Mobil Corp. (NYSE: XOM) saw its shares increase 5% since the Brexit vote. Shares closed Friday’s trading at $93.84, with a consensus analyst price target of $86.95 and a 52-week trading range of $66.55 to $93.98.

Johnson & Johnson (NYSE: JNJ) saw its stock drop initially at the Brexit news but since then it has made a solid recovery of nearly 5%. Shares of JNJ recently closed at $121.29, with a consensus analyst price target of $117.89 and a 52-week trading range of $81.79 to $121.54.

[wallst_email_signup]

Contact [email protected] for any questions or corrections.

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics. Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications. A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561